Day End Prices will be available on InvestorsLounge.com !


The Searle Company - A Primer – By Shajar Research

  • By: Shajar Capital Pakistan (Private) Limited

  • - Published: Tuesday, 05 September 2017
SEARL.jpg
<ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">The Searle Co. (SEARL) being one of the largest local pharmaceutical companies in Pakistan was incorporated as a subsidiary of G.D Searle &amp; Co., USA in 1965 as a Pvt Ltd Company and its shares were floated on KSE and ISE in 1993. SEARL has major stakes in IBL HealthCare Ltd (IBLHL)-74.2%. The Company has sold its 70.34% shareholding in Nextar Pharma (Pvt) Ltd at a price of PkR170.7 to its wholly owned subsidiary: Searle Biosciences (Pvt) Ltd as notified on 7th July 2017.</span></li><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">SEARL has 3 reportable segments with following proportions in total revenue: Pharmaceutical (87%), Consumer (12%) and Investment Property (1%).</span></li><li><span style="font-family:Arial, He...

Similar Reports